New Oral Medication That Could Arrest Autoimmune Diseases In its early Stages

by Medindia Content Team on  March 8, 2005 at 3:16 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

New Oral Medication That Could Arrest Autoimmune Diseases In its early Stages
Researchers say they have found a way to prevent type 1 diabetes in rats that are generally prone to develop the disease. In the past researchers discovered the human protein zonulin and found it is produced in very large amounts in people with autoimmune diseases. This overproduction triggers a number of other reactions that lead to the production of antibodies that can destroy insulin-producing cells in people genetically predisposed to develop type 1 diabetes.

In a more recent study, researchers used diabetes-prone rats to test the effectiveness of a zonulin inhibitor peptide called AT-1001. The peptide prevented diabetes from developing in the vast majority of animals tested.

Thus researchers conclude saying that this discovery could eventually lead to the development of an oral medication to arrest autoimmune diseases in the early stages.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Systemic Lupus Erythematosus Chemotherapy Chemotherapy Drugs Multiple Sclerosis Myasthenia Gravis Healthy Living Multiple Sclerosis Treatment and Modify Vitiligo Autoimmune Disorders Wegener’s Granulomatosis 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive